Antitumor activity of α‐pinene in T‐cell tumors
Cancer Science · 2024-04 · 115 (4) · 1317-1332
DOI: 10.1111/cas.16086 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, online erschienen am 26.01.2024. Verfasst von Masaya Abe und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, O…. Hauptthemen laut MEDLINE: Neoplasms, Hematologic Neoplasms, Bicyclic Monoterpenes. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Teraoka Scholarship Foundation, Wesco Scientific Promotion Foundation, Wesco Science Foundation.
Abstract (Originalsprache)
T‐cell acute leukemia and lymphoma have a poor prognosis. Although new therapeutic agents have been developed, their therapeutic effects are suboptimal. α‐Pinene, a monoterpene compound, has an antitumor effect on solid tumors; however, few comprehensive investigations have been conducted on its impact on hematologic malignancies. This report provides a comprehensive analysis of the potential benefits of using α‐pinene as an antitumor agent for the treatment of T‐cell tumors. We found that α‐pinene inhibited the proliferation of hematologic malignancies, especially in T‐cell tumor cell lines EL‐4 and Molt‐4, induced mitochondrial dysfunction and reactive oxygen species accumulation, and inhibited NF‐κB p65 translocation into the nucleus, leading to robust apoptosis in EL‐4 cells. Collectively, these findings suggest that α‐pinene has potential as a therapeutic agent for T‐cell malignancies, and further investigation is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan.
- Division of Hematology, Department of Medicine, Kobe University Hospital, Kobe, Japan.
- Department of Regenerative Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- Department of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
- Division of Medical Support, Okayama University Hospital, Okayama, Japan.
ORCID-Profile: Noboru Asada
Förderung
- Teraoka Scholarship Foundation
- Wesco Scientific Promotion Foundation
- Wesco Science Foundation
Zitieren
APA
Abe, M., Asada, N., Kimura, M., Fukui, C., Yamada, D., Wang, Z., Miyake, M., Takarada, T., Ono, M., Aoe, M., Kitamura, W., Matsuda, M., Moriyama, T., Matsumura, A., & Maeda, Y. (2024). Antitumor activity of α‐pinene in T‐cell tumors. Cancer Science, 115(4), 1317-1332. https://doi.org/10.1111/cas.16086
Vancouver
Abe M, Asada N, Kimura M, Fukui C, Yamada D, Wang Z, et al. Antitumor activity of α‐pinene in T‐cell tumors. Cancer Science. 2024;115(4):1317-1332. doi:10.1111/cas.16086
BibTeX
@article{Abe2024,
author = {Abe, Masaya and Asada, Noboru and Kimura, Maiko and Fukui, Chie and Yamada, Daisuke and Wang, Ziyi and Miyake, Masayuki and Takarada, Takeshi and Ono, Mitsuaki and Aoe, Michinori and Kitamura, Wataru and Matsuda, Masayuki and Moriyama, Takashi and Matsumura, Akifumi and Maeda, Yoshinobu},
title = {Antitumor activity of α‐pinene in T‐cell tumors},
journal = {Cancer Science},
year = {2024},
volume = {115},
number = {4},
pages = {1317--1332},
doi = {10.1111/cas.16086}
}
EUVIMED